Christopher J. Logothetis
Author
Alternate names C. J. Logothetis, Christopher J. Logothetis, C. Logothetis, Christopher Logothetis, C. J. Logothetis
Past institutions The University of Texas MD Anderson Cancer Center, Spanish Oncology Genitourinary Group, Texas Oncology, Institute of Oncology Research, John Wiley & Sons (United States) +5 more
ORCID: Yes
H-index: 117
I10-index: 408
Works count: 1,084
Citations count: 74,710
Abiraterone and Increased Survival in Metastatic Prostate Cancer
2011 · Johann S. de Bono, Christopher J. Logothetis, et al. · New England Journal of Medicine
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
2012 · Charles J. Ryan, Matthew R. Smith, et al. · New England Journal of Medicine
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
2016 · Howard I. Scher, Michael J. Morris, et al. · Journal of Clinical Oncology